• Go to navigation
  • Jump to main content
Angelini Industries Angelini Industries
  • About us

    A solid future rests on a virtuous past: this is our history, our present and our ideas about tomorrow.

    • Angelini Industries
    • Governance
    • Purpose, Vision and Values
    • Historical milestones
    • Brand Identity
  • Our industries

    A solid presence in various sectors and a portfolio of market-leading brands: we are this, and much more.

    • Health
    • Consumer Goods
    • Industrial Technology
  • Financials

    • Financial Data
    • 6/25/2025
      Categories:
      Industries

      Angelini Industries: in 2024 net income up 30% to € 156 million. Group revenues (+3%) and EBITDA (+17%) also on the rise

  • Sustainability

    • Sustainability
    • People
    • Patients, Clients and Community
    • Ecosystem
    • Planet
  • Angelini Academy
  • Newsroom
  • At a Glance
  • Back to the main menu

    Language

    • English Current language
    • Italiano

Press releases and news

Filtra

  • Year
  • Industries

Year

All filters

Industries

All filters

No results found with the selected filters

Try to use different filters.

  1. 12/22/2020
    Categories:
    Consumer Goods

    MadreNatura and Angelini Foundation: food adoption kicks off in collaboration with Banco Alimentare Lombardia and Abruzzo

  2. 12/1/2020

    Sergio Marullo di Condojanni (Angelini Holding) participates in the G20 Business Summit - B20

  3. 10/1/2020

    Angelini Holding partecipates the CSR and Social Innovation Show

  4. 9/22/2020

    Angelini: five hundred thousand liters of Amuchina to schools

  5. 9/9/2020

    Luxottica and Fameccanica start the national production of face masks at PalaLuxottica in Agordo

  6. 7/8/2020

    Piero Tansella joins Angelini Holding to coordinate and develop the Group Business Consumer unit

  7. 6/23/2020

    Hero Group, Angelini Holding launch new baby food business in Italy

  8. 6/16/2020
    Categories:
    Industries

    Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe

88 of 127 results displayed
Go to the previous page Go to the next page
You are in:
  1. Home
  2. Press Room
  3. Press releases and news
Scroll to top

Angelini Holding S.p.A.

Società per azioni con socio unico

Viale Amelia, 70 - 00181 Roma

Sustainability

Our industries

Financials

ABOUT US

Newsroom

WHERE WE ARE

  • Privacy policy
  • Cookie Policy
  • Terms and conditions
  • Site map
  • Whistleblowing
  • Webscraping
  • Cookie settings
  • Linkedin
  • Facebook
  • Instagram
  • YouTube

©2023 Angelini Holding S.p.A. - Tutti i diritti riservati - CF e n° iscrizione Reg. Impr. di Roma 00459650586 - P. IVA n° 00898181003 - Capitale sociale euro 3.000.000 i.v. - R.E.A. di Roma 48408

>